RESUMO
Background: Metabolic syndrome (MetS) in children is a rising health issue that is strongly associated with cardiovascular diseases and type 2 diabetes mellitus development. Low-affinity antibodies reactive to leptin and ghrelin are suggested to regulate hormone stability and function; nevertheless, the role of the leptin/ghrelin axis and antibodies reactive to both hormones in relation to MetS or its components in the pediatric population remains unknown. Methods: Fifty-eight children (7-12 years) were included and categorized according to the presence of one or more criteria for the diagnosis of MetS or according to body mass index. Body composition, biochemical variables, and metabolic risk indexes were determined. Antibodies reactive to leptin and ghrelin were quantified by an in-house enzyme-linked immunosorbent assay test. Ratios of leptin/ghrelin hormones and anti-leptin/anti-ghrelin immune complexes were obtained. Results: The biochemical variables glucose (P = 0.0009), insulin (P = 0.0001), leptin (P = 0.0036), HOMA-IR (homeostatic model assessment for insulin resistance) (P < 0.0001), and plasma atherogenic index (P < 0.0001) were significantly higher in children with two or three components of MetS (MetS 2-3) in comparison to children with none or one component (MetS 0-1). Ratios of leptin/ghrelin (P = 0.0307) and anti-leptin/anti-ghrelin immune complexes (P = 0.0338) were higher in MetS 2-3 group versus MetS 0-1 group. In MetS 2-3 group, both insulin (r = 0.4361, P = 0.0293) and HOMA-IR (r = 0.4761, P = 0.0161) were positively correlated with the leptin/ghrelin hormone ratio. Conclusions: The higher leptin/ghrelin hormone ratio scores observed in MetS 2-3 group, along with their correlation with insulin levels and HOMA-IR, highlight the role of leptin and ghrelin on insulin sensitivity and metabolic regulation. An increased ratio of anti-leptin/anti-ghrelin immune complexes suggests affinity changes in these antibodies that may lead to alterations in hormone function.
RESUMO
Introduction: CD36 is a receptor involved in physiologic, metabolic and pathologic processes. Due to its affinity for long-chain fatty acids, it has been postulated as a taste receptor of fatty taste. In this review, the emerging genetic evidence linking CD36 to oral fat perception is analyzed. A systematic literature search was conducted in PubMed, published articles from 2000 to 2022 were considered. Multiple studies have shown an association of some genetic variants in CD36 with fat foods preferences and it has been suggested that these variants can modify oral fat perception thresholds however the evidence is still heterogeneous; this can be explained by the genetic diversity of populations, the nutritional status and participant's characteristics, as well as other methodological aspects. Other factors involved in oral fat perception were and identified and discussed including the interaction with other flavors, hormones, and epigenetic factors. The conclusion is that the evidence supporting the role of CD36 as a dietary lipid receptor, the role of its genetic variants in fat acids oral perception thresholds and food preferences is intermediate level and more investigations are necessary in other populations with large number of participants as well as considering the interaction between different hormones and the expression of CD36.
Introducción: CD36 es un receptor involucrado en procesos fisiológicos, metabólicos y patológicos. Debido a su afinidad por ácidos grasos de cadena larga es uno de los principales receptores de lípidos provenientes de la dieta. En esta revisión se analiza la evidencia genética emergente que vincula a CD36 en la percepción oral de grasa. Se realizó una búsqueda sistemática en la base de datos PubMed considerando artículos publicados en el periodo 2000-2022. Múltiples estudios asocian a algunas variantes genéticas en CD36 con las preferencias por alimentos con contenido graso y se ha postulado que estas variantes pueden modificar los umbrales de percepción oral de grasas, sin embargo, la evidencia es heterogénea; esto puede ser explicado por la diversidad genética de las poblaciones, el estado nutricional y características de los participantes, así como a otros aspectos metodológicos. Se identificaron y se discuten otros factores implicados en la percepción oral de grasas, incluyendo la interacción con otros sabores, hormonas y factores epigenéticos. Se concluye que la evidencia que apoya el papel de CD36 como receptor de los lípidos provenientes de la dieta es intermedio y son necesarias más investigaciones en diversas poblaciones con un gran número de participantes, así como considerar la interacción entre distintas hormonas y la expresión de CD36.
Assuntos
Preferências Alimentares , Papilas Gustativas , Humanos , Antígenos CD36/genética , Antígenos CD36/metabolismo , Gorduras na Dieta/metabolismo , Ácidos Graxos/metabolismo , Hormônios/metabolismo , Papilas Gustativas/metabolismo , Percepção Gustatória/genéticaRESUMO
Triple-negative breast cancer (TNBC) occurs more frequently in young (<50 years) non-Hispanic black and Hispanic/Latina women. It is considered the most aggressive subtype of breast cancer, although, recently, immune infiltrate has been associated with long-term survival, lower risk of death and recurrence, and response to neoadjuvant chemotherapy. The aim of this review was to evaluate the clinical impact of the immune infiltrate in TNBC by discussing whether its prognostic value varies across different populations. A comprehensive systematic search in databases such as PubMed and Web of Science was conducted to include papers focused on tumor-infiltrating lymphocytes (TILs) in TNBC in different population groups and that were published before January 2021. TNBC patients with higher levels of TILs had longer overall survival and disease-free survival times compared with TNBC patients with low TIL levels. Similar results were observed for CD4+, CD8+ TIL populations. On the other hand, patients with high TIL levels showed a higher rate of pathological complete response regardless of the population group (Asian, European, and American). These results altogether suggest that TIL subpopulations might have a prognostic role in TNBC, but the underlying mechanism needs to be elucidated. Although the prognosis value of TILs was not found different between the population groups analyzed in the revised literature, further studies including underrepresented populations with different genetic ancestries are still necessary to conclude in this regard.
RESUMO
CD36 es un receptor involucrado en procesos fisiológicos, metabólicos y patológicos. Debido a su afinidad por ácidos grasos de cadena larga es uno de los principales receptores de lípidos provenientes de la dieta. En esta revisión se analiza la evidencia genética emergente que vincula a CD36 en la percepción oral de grasa. Se realizó una búsqueda sistemática en la base de datos PubMed considerando artículos publicados en el periodo 2000-2022. Múltiples estudios asocian a algunas variantes genéticas en CD36 con las preferencias por alimentos con contenido graso y se ha postulado que estas variantes pueden modificar los umbrales de percepción oral de grasas, sin embargo, la evidencia es heterogénea; esto puede ser explicado por la diversidad genética de las poblaciones, el estado nutricional y características de los participantes, así como a otros aspectos metodológicos. Se identificaron y se discuten otros factores implicados en la percepción oral de grasas, incluyendo la interacción con otros sabores, hormonas y factores epigenéticos. Se concluye que la evidencia que apoya el papel de CD36 como receptor de los lípidos provenientes de la dieta es intermedio y son necesarias más investigaciones en diversas poblaciones con un gran número de participantes, así como considerar la interacción entre distintas hormonas y la expresión de CD36. (AU)
CD36 is a receptor involved in physiologic, metabolic and pathologic processes. Due to its affinity for long-chain fatty acids, it has been postulated as a taste receptor of fatty taste. In this review, the emerging genetic evidence linking CD36 to oral fat perception is analyzed. A systematic literature search was conducted in PubMed, published articles from 2000 to 2022 were considered. Multiple studies have shown an association of some genetic variants in CD36 with fat foods preferences and it has been suggested that these variants can modify oral fat perception thresholds however the evidence is still heterogeneous; this can be explained by the genetic diversity of populations, the nutritional status and participants characteristics, as well as other methodological aspects. Other factors involved in oral fat perception were and identified and discussed including the interaction with other flavors, hormones, and epigenetic factors. The conclusion is that the evidence supporting the role of CD36 as a dietary lipid receptor, the role of its genetic variants in fat acids oral perception thresholds and food preferences is intermediate level and more research is necessary in other populations with large number of participants as well as considering the interaction between different hormones and the expression of CD36. (AU)
Assuntos
Humanos , Antígenos CD36/genética , Preferências Alimentares , Percepção Gustatória , Ácidos Graxos , Gorduras na DietaRESUMO
Introducción: En Colombia son escasos los datos sobre el uso de los inhaladores en pacientes con EPOC. Objetivo: Describir la técnica de uso de inhaladores de dosis medida y polvo seco en pacientes de un hospital colombiano. Materiales y métodos: Estudio descriptivo en pacientes mayores de 40 años con EPOC atendidos en un hospital en La Virginia, Risaralda, Colombia, entre el 1 de septiembre de 2019 al 31 de enero de 2020. La unidad de análisis fueron los pacientes. Se incluyeron variables sociodemográficas, clínicas y lista de chequeo para uso de inhaladores. Se aplicaron frecuencias y proporciones para variables discretas, estadísticas de tendencia central y dispersión para variables continuas. Resultados: Se incluyeron 104 pacientes con edad media de 73,6 ± 10,1 años; 57 eran mujeres (54,8 %). Además, 48 pacientes estaban clasificados como GOLD-D (46,2 %). Igualmente, 89 pacientes manifestaron haber recibido educación sobre el uso de broncodilatadores (85,6 %). Los más frecuentes fueron los inhaladores de dosis medida (DM) en 95 casos (91,3 %), seguido de los de polvo seco unidosis (7,7 %). Así mismo, 37 pacientes que usaron DM sin inhalocámara (35,6 %) no cumplieron los pasos de la lista de chequeo. En el sistema multidosis, el más realizado fue cerrar de manera adecuada el inhalador y el menos ejecutado, expulsar el aire lentamente evitando hacerlo cerca del inhalador (n = 6; 5,7 %). Discusión: Se lograron describir las características de la técnica de uso de los inhaladores en pacientes con EPOC. A pesar de que ningún paciente logró utilizar el inhalador de forma "perfecta", la mayoría han recibido educación por parte de los profesionales de la salud. Conclusión: Un alto porcentaje de pacientes usa inadecuadamente los dispositivos para suministrar los broncodilatadores. Esto puede impactar negativamente en el control de la enfermedad.
Introduction: In Colombia, there is limited data on the use of inhalers in patients with COPD. Objective: The objective was to describe the technique of using metered-dose inhalers and dry powder in patients in a Colombian hospital. Methods: Observational, descriptive study of patients over 40 years of age with COPD, treated in a hospital in La Virginia, Risaralda, Colombia, between September 1st, 2019 and January 31st, 2020. The unit of analysis were patients in consultation. Sociodemographic and clinical variables, and a checklist for use of inhalers were included. Frequencies and proportions were applied for discrete variables, statistics of central tendency and dispersion for continuous variables. Results: A total of 104 patients with an average age of 73.6 ± 10.1 years were included; 57 were women (54.8%). In addition, 48 patients were classified as GOLD-D (46.2%). Similarly, 89 patients reported having received education on the use of bronchodilators (85.6%). The most common were metered-dose (MD) inhalers in 95 cases (91.3%), followed by single-dose dry powder inhalers in eight patients (7.7%). Likewise, 37 patients who used DM without inhalochamber (35.6%) did not comply with the steps of the checklist. In the multidose system, the most performed was to properly close the inhaler and the least performed was to expel the air slowly, avoiding doing so near the inhaler (n=6; 5.7%). Discussion: The characteristics of the technique of using inhalers in patients with COPD were described. Although no patient was able to use the inhaler "perfectly", most have received education from health professionals. Conclusion: A high percentage of patients misuse the devices to deliver bronchodilators. This can negatively impact the control of the disease.
RESUMO
Resumen La obesidad constituye un problema de salud a nivel mundial y una de las principales causas de las enfermedades crónicas. Existen diversos factores que influyen en el comportamiento alimentario y la obesidad, los cuales pueden ser genéticos, fisiológicos, nutricionales, psicológicos o socioculturales. En las últimas décadas, el cambio en el estilo de vida ha provocado patrones de alimentación inadecuados, aunados a disminución en el gasto energético. En esta revisión se describen los principales factores fisiológicos, nutricionales y psicológicos que intervienen en la ingesta energética y el comportamiento alimentario, y cómo es que estos pueden −vía la regulación del apetito y del peso corporal− influir en el desarrollo de la obesidad. La neuropsicología de la recompensa de los alimentos, de las preferencias, de la elección y del comportamiento alimentario son aspectos aún no comprendidos. Investigaciones futuras tienen que enfocarse en dilucidar las vías involucradas en los aspectos gratificantes de los alimentos y, como una alternativa para controlar la obesidad, replicar esta experiencia con alimentos más saludables. Sin embargo, la comprensión del vínculo entre alimentación, ingesta energética y regulación del peso corporal solo se logrará a través del trabajo multidisciplinario.
Abstract Obesity is a global health problem and one of the main causes of chronic diseases. There are several factors that influence eating behavior and obesity, which can be genetic, physiological, nutritional, psychological or sociocultural. In recent decades, the change in lifestyle has caused inadequate eating patterns, coupled with a decrease in energy expenditure. This review describes the main physiological, nutritional and psychological factors that intervene in energy intake and eating behavior and how they can -by regulating appetite and body weight- influence the development of obesity. The neuropsychology of food reward, preferences, choice and eating behavior are aspects not yet understood. Future research needs to focus on elucidating the pathways involved in the rewarding aspects of food and, as an alternative to control obesity, replicate this experience with healthier foods. However, understanding the link between food, energy intake and body weight regulation will only be achieved through multidisciplinary work.